Jing Y.

Jing Y. is an experienced professional in the field of analytical development and quality control, currently serving as the Director of Analytical Development & Quality Control at Zenas BioPharma since June 2022. Prior to this role, Jing Y. held the position of Associate Director/Senior Scientist in Biologics Analytical Development at Nektar Therapeutics from June 2019 to June 2022. Additionally, Jing Y. was a QC Manager at Stemcentrx, part of AbbVie, from March 2017 to May 2019, and worked as a Research Scientist in Commercial Analytical Operations at Gilead Sciences between November 2014 and February 2017. Jing Y.'s earlier experience includes serving as a Senior Scientist/Research Scientist in CMC Analytical at Exelixis from February 2006 to November 2014.